rabies — TargetMol Chemicals

Cat No.	Product Name	Synonyms	Targets
TP1871	Rabies Virus Glycoprotein
	Rabies Virus Glycoprotein is a 29 amino acid fragment generated from rabies virus glycoprotein (RVG). This peptide specifically binds to the acetylcholine receptor expressed by neuronal cells.
TP1553	Rabies Virus Glycoprotein TFA
	Rabies Virus Glycoprotein (TFA) is a kind of by the Rabies Virus Glycoprotein 29 - amino acid derived cell penetrating peptides, it can pass the blood brain barrier (BBB) into the brain cells.
TP1871L	Rabies Virus Glycoprotein acetate
	Rabies Virus Glycoprotein acetate is a useful organic compound for research related to life sciences and the catalog number is TP1871L.
T80338	RVG	Rabies Virus Glycoprotein-29,RVG29,RDP
	RVG29, a peptide originating from Rabies Virus Glycoprotein, specifically targets the α-7 subunit of nicotinic acetylcholine receptors (AchR) on neuronal cells, thereby facilitating the transport of Mycobacterium tubercu...
T8701	GRP-60367		Others
	GRP-60367 is the first small molecule rabies virus (RABV) entry inhibitor, which has nanomolar effect on some RABV strains.		Others
T76555	Rabies Virus Matrix Protein Fragment(RV-MAT)
	Rabies Virus Matrix Protein Fragment (RV-MAT), a polypeptide, selectively binds to the acetylcholine receptor (AChR) located on the cell surface [1].
T21980	PD 198306		MEK
	PD 198306 is a selective inhibitor of MAPK/ERK-kinase (MEK) with antihyperalgesic effects. PD 198306 reduces the Streptozocin-induced increase in the level of active ERK1.		MEK
TP2402	Peptide VF13N	Epitope VF13N
	Peptide VF13N is a synthetic rabies virus glycoprotein T helper cell epitope.
T77081	Mazorelvimab
	Mazorelvimab (SYN023), a cocktail composed of the humanized monoclonal antibodies CTB011 and CTB012, targets the rabies virus (RABV) by binding to non-overlapping epitopes on the RABV's glycoprotein (G). This interaction...
T80589	Zamerovimab	SYN023,CTB011
	Zamerovimab (CTB011; SYN023), a composite of human monoclonal antibodies CTB011 and CTB012, targets distinct, non-overlapping epitopes on the rabies virus (RABV) glycoprotein, with CTB011 specifically binding to antigeni...
T78315	Foravirumab	CR4098
	Foravirumab (CR4098) is a monoclonal antibody targeting antigenic site III of the rabies virus glycoprotein [1].
T77137	Rafivirumab
	Rafivirumab (CR57) is a monoclonal antibody designed for rabies prophylaxis, exhibiting neutralizing efficacy against a wide range of rabies virus (RABV) variants. It is also utilized in cocktail research studies [1] [2]...
T61763	GRP-60367 hydrochloride
	GRP-60367 hydrochloride is a novel small-molecule entry inhibitor of rabies virus (RABV), exhibiting nanomolar potency against select RABV strains. This first-in-class compound effectively targets the RABV G protein [1].
T81789	Miromavimab	M777-16-3
	Miromavimab (M777-16-3) is a monoclonal antibody (mAb) targeting the G-II epitope within the ectodomain of the rabies virus strain ERAGP [1].
T77161	Docaravimab
	Docaravimab, an antibody designed to target the G-III epitope within the ectodomain of the Evelyn-Rockitniki-Abelseth (ERA) glycoprotein, is utilized in rabies research [1].
T62780	Antiviral agent 15
	Antiviral agent 15 (Compound 15f) is a Clofazimine derivative with antiviral activity.Antiviral agent 15 inhibits rabies virus (EC50: 1.45 μM) and pseudotyped SARS-CoV-2 (EC50: 14.6 μM).
T80594	Ormutivimab	rhRIG,NM57
	Ormutivimab (rhRIG), a recombinant human monoclonal antibody designed to target the rabies virus, effectively neutralizes various strains and demonstrates strong efficacy as a post-exposure prophylaxis (PEP) treatment in...